Top Wisconsin Pharmaceutical Startups (15)
Protein Foundry produces bacterial and virus vaccines, toxoids, and analogous products.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Lumiera Health Innovation offers innovative specialty pharmacy solutions, framed in the core principles of transparency and stewardship.
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
CLG -Multi-species Stem Cell Characterization Services and Products & Custom Assay Development
Nexcyon is advancing veterinary medicine and improving the quality of life for companion animals around the world.
Splash Clinical is an innovative patient recruitment firm that’s pioneered the use of digital & social media to recruit patients for clinical trials. The company was founded to help solve the problem of patient enrollment in clinical trials by leveraging the power of social media, data analytics and mobile technologies. Our team works with Sponsor’s and CRO’s from across the globe,...
Stem Pharm's synthetic biomaterials support the optimization of cell expansion
Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.
PharmaSeek mission is to bring efficiencies to the clinical research industry by providing administrative services to sites.
A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven...
Cmxtwenty focuses on developing lipid compounds for use in non-narcotic pain treatment.
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical...
